Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.92%39.05M | -1.07%38.48M | -2.40%38.01M | -0.53%157.09M | -2.11%39.43M | -0.04%39.82M | -1.29%38.89M | 1.41%38.94M | 9.83%157.93M | 6.25%40.29M |
| Operating revenue | -1.92%39.05M | -1.07%38.48M | -2.40%38.01M | -0.53%157.09M | -2.11%39.43M | -0.04%39.82M | -1.29%38.89M | 1.41%38.94M | 9.83%157.93M | 6.25%40.29M |
| Cost of revenue | 0.36%13.49M | 0.44%14.06M | 1.29%14.69M | -3.81%56.52M | 2.27%14.58M | -4.03%13.44M | -5.60%14M | -7.46%14.5M | 4.93%58.76M | -4.78%14.25M |
| Gross profit | -3.08%25.56M | -1.92%24.42M | -4.58%23.32M | 1.41%100.57M | -4.52%24.86M | 2.12%26.38M | 1.31%24.9M | 7.51%24.44M | 12.95%99.17M | 13.44%26.03M |
| Operating expense | -43.99%2.07M | 43.05%2.71M | -1.68%2.46M | -23.24%8.48M | -89.15%378K | 111.48%3.7M | -34.73%1.89M | -13.95%2.5M | 56.47%11.04M | 19.81%3.48M |
| Selling and administrative expenses | -43.99%2.07M | 43.05%2.71M | -1.68%2.46M | -23.24%8.48M | -89.15%378K | 111.48%3.7M | -34.73%1.89M | -13.95%2.5M | 56.47%11.04M | 19.81%3.48M |
| -General and administrative expense | -43.99%2.07M | 43.05%2.71M | -1.68%2.46M | -23.24%8.48M | -89.15%378K | 111.48%3.7M | -34.73%1.89M | -13.95%2.5M | 56.47%11.04M | 19.81%3.48M |
| Operating profit | 3.60%23.49M | -5.61%21.71M | -4.91%20.86M | 4.50%92.1M | 8.56%24.48M | -5.83%22.67M | 6.13%23M | 10.66%21.94M | 9.15%88.13M | 12.52%22.55M |
| Net non-operating interest income (expenses) | -48.19%-11.34M | -4.72%-10.77M | 2.34%-10.58M | 10.94%-42.31M | -17.11%-13.54M | 34.53%-7.65M | 14.76%-10.29M | 11.14%-10.84M | -19.45%-47.51M | 1.10%-11.56M |
| Non-operating interest income | -20.32%1.61M | -14.65%1.63M | -4.60%1.82M | 6.67%7.87M | -1.79%2.03M | 6.98%2.02M | 6.40%1.91M | 17.31%1.91M | 53.20%7.38M | 38.40%2.07M |
| Non-operating interest expense | 2.04%7.04M | 5.85%7.09M | -3.78%6.94M | -19.20%27.69M | -14.98%6.88M | -15.25%6.9M | -26.10%6.7M | -19.63%7.22M | 32.42%34.27M | -2.26%8.09M |
| Total other finance cost | 112.90%5.91M | -3.38%5.32M | -1.25%5.46M | 9.10%22.5M | 56.97%8.69M | -48.95%2.78M | 14.55%5.5M | 14.14%5.53M | 10.21%20.62M | 12.86%5.54M |
| Other net income (expenses) | 25.52%-42.36M | -159.93%-12.03M | 118.01%5.39M | 108.56%13.46M | 190.86%80.16M | -468.79%-56.88M | 138.15%20.07M | 6.15%-29.9M | -185.28%-157.28M | -116.34%-88.22M |
| Gain on sale of security | -1,329.60%-47.86M | 127.06%2.35M | 122.31%8.6M | 38.93%-62.53M | 46.42%-11.94M | 84.16%-3.35M | 80.70%-8.69M | -177.06%-38.55M | -522.85%-102.38M | -82.56%-22.28M |
| Special income (charges) | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | ---1.78M | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.78M | --0 |
| Other non-operating income (expenses) | 115.88%8.5M | -146.53%-13.38M | -155.34%-4.79M | 243.04%75.98M | 239.65%92.09M | -246.39%-53.53M | 596.56%28.77M | 148.19%8.65M | -126.44%-53.12M | -130.77%-65.95M |
| Income before tax | 27.82%-30.21M | -103.32%-1.09M | 183.36%15.67M | 154.21%63.24M | 217.94%91.09M | -250.46%-41.85M | 176.24%32.79M | 22.43%-18.79M | -151.76%-116.66M | -138.15%-77.24M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 27.82%-30.21M | -103.32%-1.09M | 183.36%15.67M | 154.21%63.24M | 217.94%91.09M | -250.46%-41.85M | 176.24%32.79M | 22.43%-18.79M | -151.76%-116.66M | -138.15%-77.24M |
| Net income continuous operations | 27.82%-30.21M | -103.32%-1.09M | 183.36%15.67M | 154.21%63.24M | 217.94%91.09M | -250.46%-41.85M | 176.24%32.79M | 22.43%-18.79M | -151.76%-116.66M | -138.15%-77.24M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 27.82%-30.21M | -103.32%-1.09M | 183.36%15.67M | 154.21%63.24M | 217.94%91.09M | -250.46%-41.85M | 176.24%32.79M | 22.43%-18.79M | -151.76%-116.66M | -138.15%-77.24M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 27.82%-30.21M | -103.32%-1.09M | 183.36%15.67M | 154.21%63.24M | 217.94%91.09M | -250.46%-41.85M | 176.24%32.79M | 22.43%-18.79M | -151.76%-116.66M | -138.15%-77.24M |
| Diluted earnings per share | 21.36%-0.8246 | -103.60%-0.0296 | 186.54%0.4076 | 154.65%1.5978 | 218.89%2.3016 | -250.39%-1.0485 | 176.18%0.8215 | 22.46%-0.471 | -151.74%-2.9239 | -138.09%-1.9359 |
| Basic earnings per share | 21.36%-0.8246 | -103.60%-0.0296 | 186.54%0.4076 | 154.65%1.5978 | 218.89%2.3016 | -250.39%-1.0485 | 176.18%0.8215 | 22.46%-0.471 | -151.74%-2.9239 | -138.09%-1.9359 |
| Dividend per share | 2.97%0.13 | 2.97%0.13 | 2.97%0.13 | 3.05%0.5075 | 3.00%0.1287 | 3.06%0.1262 | 3.06%0.1262 | 3.06%0.1262 | 3.14%0.4925 | 3.09%0.125 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.